Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital

Circulating levels and prognostic value of soluble ST2 in heart failure are less influenced by age than N-terminal pro-B-type natriuretic peptide and high-sensitivity troponin T

Research output: Contribution to journalJournal articleResearchpeer-review


  1. Hypertensive disorders in women with peripartum cardiomyopathy: insights from the ESC EORP PPCM Registry

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Recovery of Cardiac Function Following COVID-19 - ECHOVID-19: A Prospective Longitudinal Cohort Study

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Urinary peptides in heart failure: a link to molecular pathophysiology

    Research output: Contribution to journalJournal articleResearchpeer-review

  • Alberto Aimo
  • James L Januzzi
  • Giuseppe Vergaro
  • A Mark Richards
  • Carolyn S P Lam
  • Roberto Latini
  • Inder S Anand
  • Jay N Cohn
  • Thor Ueland
  • Lars Gullestad
  • Pål Aukrust
  • Hans-Peter Brunner-La Rocca
  • Antoni Bayes-Genis
  • Josep Lupón
  • Rudolf A de Boer
  • Yasuchika Takeishi
  • Michael Egstrup
  • Ida Gustafsson
  • Hanna K Gaggin
  • Kai M Eggers
  • Kurt Huber
  • Greg D Gamble
  • Lieng H Ling
  • Kui Tong Gerard Leong
  • Poh Shuah Daniel Yeo
  • Hean Yee Ong
  • Fazlur Jaufeerally
  • Tze P Ng
  • Richard Troughton
  • Robert N Doughty
  • Claudio Passino
  • Michele Emdin
View graph of relations

Aims: N-terminal pro-B-type natriuretic peptide (NT-proBNP), high-sensitivity troponin T (hs-TnT) and soluble suppression of tumorigenesis-2 (sST2) predict outcome in chronic heart failure (HF). We assessed the influence of age on circulating levels and prognostic significance of these biomarkers. Methods and results: Individual data from 5301 patients with chronic HF and NT-proBNP, hs-TnT, and sST2 data were evaluated. Patients were stratified according to age: <60 years (n = 1332, 25%), 60–69 years (n = 1628, 31%), 70–79 years (n = 1662, 31%), and ≥ 80 years (n = 679, 13%). Patients (median age 66 years, 75% men, median left ventricular ejection fraction 28%, 64% with ischaemic HF) had median NT-proBNP 1564 ng/L, hs-TnT 21 ng/L, and sST2 29 ng/mL. Age independently predicted NT-proBNP and hs-TnT, but not sST2. The best NT-proBNP and hs-TnT cut-offs for 1-year and 5-year all-cause and cardiovascular mortality and 1- to 12-month HF hospitalization increased with age, while the best sST2 cut-offs did not. When stratifying patients according to age- and outcome-specific cut-offs, this stratification yielded independent prognostic significance over NT-proBNP levels only, or the composite of NT-proBNP and hs-TnT, and improved risk prediction for most endpoints. Finally, absolute NT-proBNP, hs-TnT, and sST2 levels predicted outcomes independent of age, sex, left ventricular ejection fraction category, ethnic group, and other variables. Conclusions: Soluble ST2 is less influenced by age than NT-proBNP or hs-TnT; all these biomarkers predict outcome regardless of age. The use of age- and outcome-specific cut-offs of NT-proBNP, hs-TnT and sST2 allows more accurate risk stratification than NT-proBNP alone or the combination of NT-proBNP and hs-TnT.

Original languageEnglish
JournalEuropean Journal of Heart Failure
Issue number11
Pages (from-to)2078-2088
Number of pages11
Publication statusPublished - Nov 2020

Bibliographical note

© 2019 European Society of Cardiology.

    Research areas

  • Age, Biomarkers, Heart failure, Prognosis, sST2

ID: 59425584